It is a remarkable time in biomedical research, as we now can effectively treat and even cure many diseases in cells that are currently untreatable in patients. Realizing the potential of these innovations in the clinic remains a central challenge, largely due to the barriers in delivering these novel treatments in humans. Solving this problem arguably will be one of the most pivotal breakthroughs in medicine.
Scott Davis holds degrees in physics, mechanical and biomedical engineering, and brings broad technical expertise to the team as well as hands-on startup experience.
Scott is a professor of engineering at Dartmouth College developing new optically-based cancer imaging techniques and contributes to the GV team on a part-time basis. Prior to his doctoral work in medical imaging, he was a key contributor to the success of Burlee.com, a leading Web hosting company acquired by Interland, Inc., now Web.com.
Scott received a B.A. with honors in physics from Middlebury College, an M.S. in mechanical and aerospace engineering from the University of Virginia, and a Ph.D. in biomedical engineering from Dartmouth College.
It is a remarkable time in biomedical research, as we now can effectively treat and even cure many diseases in cells that are currently untreatable in patients. Realizing the potential of these innovations in the clinic remains a central challenge, largely due to the barriers in delivering these novel treatments in humans. Solving this problem arguably will be one of the most pivotal breakthroughs in medicine.